Preoperative CT deep learning of tumor and visceral adipose tissue combined with postoperative pathology predicts colorectal cancer recurrence: a multicenter study.
{"title":"Preoperative CT deep learning of tumor and visceral adipose tissue combined with postoperative pathology predicts colorectal cancer recurrence: a multicenter study.","authors":"Pengfei Wei, Linhua Zhong, Yongming Tan, Jinhong Zhao, Yongjie Zhou","doi":"10.3389/fmolb.2026.1937172","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>To develop and externally validate a preoperative CT imaging model integrating primary tumour and visceral adipose tissue (VAT) features for predicting recurrence in colorectal cancer (CRC).</p><p><strong>Materials and methods: </strong>This retrospective multicentre study included 1,369 patients with CRC undergoing upfront curative-intent resection, comprising a training cohort (n = 705) and two external test cohorts (n = 425 and 239). A 3D convolutional neural network extracted tumour-centred volumetric features, while an attention-based multiple instance learning branch aggregated whole-abdominal VAT slices into patient-level representations. The two CT-derived scores constituted the preoperative imaging model. A clinicopathological component was combined with the imaging scores to construct the postoperative multimodal model; robustness to variable selection was evaluated using an all-candidate ridge-penalised Cox sensitivity model.</p><p><strong>Results: </strong>Both tumour and VAT DL scores remained independently associated with recurrence-free survival after multivariable adjustment. In external test cohorts 1 and 2, the preoperative Tumor + VAT imaging model achieved C-indices of 0.734 and 0.772, whereas the postoperative multimodal model achieved C-indices of 0.772 and 0.810 and 2-year time-dependent AUCs of 0.757 and 0.836, respectively. Training-derived tertile cut-offs from the postoperative model consistently stratified patients into low-, intermediate- and high-risk groups across all cohorts (all log-rank P < 0.001). In the two external cohorts, the clinicopathological-only model achieved C-indices of 0.709 and 0.715, compared with 0.772 and 0.810 for the postoperative multimodal model.</p><p><strong>Conclusion: </strong>The preoperative CT model non-invasively stratified recurrence risk using tumour and whole-abdominal VAT phenotypes, while postoperative clinicopathological features further improved prognostic performance.</p>","PeriodicalId":12465,"journal":{"name":"Frontiers in Molecular Biosciences","volume":"13 ","pages":"1937172"},"PeriodicalIF":4.4000,"publicationDate":"2026-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13646159/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Molecular Biosciences","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.3389/fmolb.2026.1937172","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: To develop and externally validate a preoperative CT imaging model integrating primary tumour and visceral adipose tissue (VAT) features for predicting recurrence in colorectal cancer (CRC).
Materials and methods: This retrospective multicentre study included 1,369 patients with CRC undergoing upfront curative-intent resection, comprising a training cohort (n = 705) and two external test cohorts (n = 425 and 239). A 3D convolutional neural network extracted tumour-centred volumetric features, while an attention-based multiple instance learning branch aggregated whole-abdominal VAT slices into patient-level representations. The two CT-derived scores constituted the preoperative imaging model. A clinicopathological component was combined with the imaging scores to construct the postoperative multimodal model; robustness to variable selection was evaluated using an all-candidate ridge-penalised Cox sensitivity model.
Results: Both tumour and VAT DL scores remained independently associated with recurrence-free survival after multivariable adjustment. In external test cohorts 1 and 2, the preoperative Tumor + VAT imaging model achieved C-indices of 0.734 and 0.772, whereas the postoperative multimodal model achieved C-indices of 0.772 and 0.810 and 2-year time-dependent AUCs of 0.757 and 0.836, respectively. Training-derived tertile cut-offs from the postoperative model consistently stratified patients into low-, intermediate- and high-risk groups across all cohorts (all log-rank P < 0.001). In the two external cohorts, the clinicopathological-only model achieved C-indices of 0.709 and 0.715, compared with 0.772 and 0.810 for the postoperative multimodal model.
Conclusion: The preoperative CT model non-invasively stratified recurrence risk using tumour and whole-abdominal VAT phenotypes, while postoperative clinicopathological features further improved prognostic performance.
期刊介绍:
Much of contemporary investigation in the life sciences is devoted to the molecular-scale understanding of the relationships between genes and the environment — in particular, dynamic alterations in the levels, modifications, and interactions of cellular effectors, including proteins. Frontiers in Molecular Biosciences offers an international publication platform for basic as well as applied research; we encourage contributions spanning both established and emerging areas of biology. To this end, the journal draws from empirical disciplines such as structural biology, enzymology, biochemistry, and biophysics, capitalizing as well on the technological advancements that have enabled metabolomics and proteomics measurements in massively parallel throughput, and the development of robust and innovative computational biology strategies. We also recognize influences from medicine and technology, welcoming studies in molecular genetics, molecular diagnostics and therapeutics, and nanotechnology.
Our ultimate objective is the comprehensive illustration of the molecular mechanisms regulating proteins, nucleic acids, carbohydrates, lipids, and small metabolites in organisms across all branches of life.
In addition to interesting new findings, techniques, and applications, Frontiers in Molecular Biosciences will consider new testable hypotheses to inspire different perspectives and stimulate scientific dialogue. The integration of in silico, in vitro, and in vivo approaches will benefit endeavors across all domains of the life sciences.